|
1
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oh BS, Jang JW, Kwon JH, You CR, Chung KW,
Kay CS, Jung HS and Lee S: Prognostic value of C-reactive protein
and neutrophil-to-lymphocyte ratio in patients with hepatocellular
carcinoma. BMC Cancer. 13:782013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu
L and Chen M: Postoperative neutrophil-to-lymphocyte ratio change
predicts survival of patients with small hepatocellular carcinoma
undergoing radiofrequency ablation. PLoS One. 8:e581842013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lopes M, Carvalho B, Vaz R and Linhares P:
Influence of neutrophil-lymphocyte ratio in prognosis of
glioblastoma multiforme. J Neurooncol. 136:173–180. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luo G, Liu C, Cheng H, Jin K, Guo M, Lu Y,
Long J, Xu J, Ni Q, Chen J and Yu X: Neutrophil-lymphocyte ratio
predicts survival in pancreatic neuroendocrine tumors. Oncol Lett.
13:2454–2458. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin H, Sun J, Zhu K, Liu X, Zhang Q, Shen
Q, Gao Y and Yu J: The prognostic value of neutrophil-lymphocyte
ratio is superior to derived neutrophil-lymphocyte ratio in
advanced gastric cancer treated with preoperative chemotherapy and
sequential R0 resection: A 5-year follow-up. Onco Targets Ther.
10:2655–2664. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Komura N, Mabuchi S, Yokoi E, Kozasa K,
Kuroda H, Sasano T, Matsumoto Y and Kimura T: Comparison of
clinical utility between neutrophil count and neutrophil-lymphocyte
ratio in patients with ovarian cancer: A single institutional
experience and a literature review. Int J Clin Oncol. 23:104–113.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun Z, Ju Y, Han F, Sun X and Wang F:
Clinical implications of pretreatment inflammatory biomarkers as
independent prognostic indicators in prostate cancer. J Clin Lab
Anal. 32:e222772018. View Article : Google Scholar
|
|
9
|
Ethier JL, Desautels D, Templeton A, Shah
PS and Amir E: Prognostic role of neutrophil-to-lymphocyte ratio in
breast cancer: A systematic review and meta-analysis. Breast Cancer
Res. 19:22017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee SK, Choi MY, Bae SY, Lee JH, Lee HC,
Kil WH, Lee JE, Kim SW and Nam SJ: Immediate postoperative
inflammation is an important prognostic factor in breast cancer.
Oncology. 88:337–344. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shibutani M, Maeda K, Nagahara H, Ohtani
H, Iseki Y, Ikeya T, Sugano K and Hirakawa K: The prognostic
significance of a postoperative systemic inflammatory response in
patients with colorectal cancer. World J Surg Oncol. 13:1942015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lalani AA, Xie W, Martini DJ, Steinharter
JA, Norton CK, Krajewski KM, Duquette A, Bossé D, Bellmunt J, Van
Allen EM, et al: Change in Neutrophil-to-lymphocyte ratio (NLR) in
response to immune checkpoint blockade for metastatic renal cell
carcinoma. J Immunother Cancer. 6:52018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li M, Spakowicz D, Burkart J, Patel S,
Husain M, He K, Bertino EM, Shields PG, Carbone DP, Verschraegen
CF, et al: Change in neutrophil to lymphocyte ratio during
immunotherapy treatment is a non-linear predictor of patient
outcomes in advanced cancers. J Cancer Res Clin Oncol.
145:2541–2546. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyatani K, Saito H, Kono Y, Murakami Y,
Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K and Fujiwara
Y: Combined analysis of the pre- and postoperative
neutrophil-lymphocyte ratio predicts the outcomes of patients with
gastric cancer. Surg Today. 48:300–307. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng W, Li C, Wen TF, Yan LN, Li B, Wang
WT, Yang JY and Xu MQ: Neutrophil to lymphocyte ratio changes
predict small hepatocellular carcinoma survival. J Surg Res.
192:402–408. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo D, Han A, Jing W, Chen D, Jin F, Li M,
Kong L and Yu J: Preoperative to postoperative change in
neutrophil-to-lymphocyte ratio predict survival in colorectal
cancer patients. Future Oncol. 14:1187–1196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jin F, Han A, Shi F, Kong L and Yu J: The
postoperative neutrophil-to-lymphocyte ratio and changes in this
ratio predict survival after the complete resection of stage I
non-small cell lung cancer. OncoTargets Ther. 9:6529–6537. 2016.
View Article : Google Scholar
|
|
19
|
Min KW, Kwon MJ, Kim DH, Son BK, Kim EK,
Oh YH and Wi YC: Persistent elevation of postoperative
neutrophil-to-lymphocyte ratio: A better predictor of survival in
gastric cancer than elevated preoperative neutrophil-to-lymphocyte
ratio. Sci Rep. 7:139672017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou ZQ, Pang S, Yu XC, Xue Q, Jiang HY,
Liang XJ and Liu L: Predictive values of postoperative and dynamic
changes of inflammation indexes in survival of patients with
resected colorectal cancer. Curr Med Sci. 38:798–808. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nishihara K, Suekane S, Ueda K, Nakiri M,
Matsuo M and Igawa T: High postoperative neutrophil-to-lymphocyte
ratio as a poorprognostic marker in patients with upper tract
urothelial carcinoma. Oncol Lett. 17:5241–5250. 2019.PubMed/NCBI
|
|
22
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Martins-Filho SN, Paiva C, Azevedo RS and
Alves VAF: Histological grading of hepatocellular carcinoma-a
systematic review of literature. Front Med (Lausanne). 4:1932017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang SS, Xie DM, Cai YJ, Wu JM, Chen RC,
Wang XD, Song M, Zheng MH, Wang YQ, Lin Z and Shi KQ: C-reactive
protein-to-albumin ratio is a predictor of hepatitis B virus
related decompensated cirrhosis: Time-dependent receiver operating
characteristics and decision curve analysis. Eur J Gastroenterol
Hepatol. 29:472–480. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kamarudin AN, Cox T and Kolamunnage-Dona
R: Time- dependent ROC curve analysis in medical research: Current
methods and applications. BMC Med Res Methodol. 17:532017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hothorn T and Zeileis A: Generalized
maximally selected statistics. Biometrics. 64:1263–1269. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Martin D, Rodel F, Balermpas P, Winkelmann
R, Fokas E and Rodel C: C-reactive protein-to-albumin ratio as
prognostic marker for anal squamous cell carcinoma treated with
chemoradiotherapy. Front Oncol. 9:12002019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z,
Chen EB, Fan J, Cao Y, Dai Z and Zhou J: Tumor-associated
neutrophils recruit macrophages and T-regulatory cells to promote
progression of hepatocellular carcinoma and resistance to
sorafenib. Gastroenterology. 150:1646–1658 e1617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakagawa S, Umezaki N, Yamao T, Kaida T,
Okabe H, Mima K, Imai K, Hashimoto D, Yamashita YI, Ishiko T, et
al: Survival impact of lymphocyte infiltration into the tumor of
hepatocellular carcinoma in hepatitis B virus-positive or non-B
non-C patients who underwent curative resection. Hepatol Res.
48:E126–E132. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morizawa Y, Miyake M, Shimada K, Hori S,
Tatsumi Y, Nakai Y, Onishi S, Tanaka N, Konishi N and Fujimoto K:
Correlation of immune cells and cytokines in the tumor
microenvironment with elevated neutrophil-to-lymphocyte ratio in
blood: An analysis of muscle-invasive bladder cancer. Cancer
Invest. 36:395–405. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bergmann J, Muller M, Baumann N, Reichert
M, Heneweer C, Bolik J, Lücke K, Gruber S, Carambia A, Boretius S,
et al: IL-6 trans-signaling is essential for the development of
hepatocellular carcinoma in mice. Hepatology. 65:89–103. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cools-Lartigue J, Spicer J, McDonald B,
Gowing S, Chow S, Giannias B, Bourdeau F, Kubes P and Ferri L:
Neutrophil extracellular traps sequester circulating tumor cells
and promote metastasis. J Clin Invest. 123:3446–3458. 2013.
View Article : Google Scholar
|
|
33
|
Li C, Wen TF, Yan LN, Li B, Wang WT, Yang
JY and Xu MQ: Postoperative neutrophil-to-lymphocyte ratio plus
platelet-to-lymphocyte ratio predicts the outcomes of
hepatocellular carcinoma. J Surg Res. 198:73–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cook NR: Use and misuse of the receiver
operating characteristic curve in risk prediction. Circulation.
115:928–935. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Medina Fernandez FJ, Munoz-Casares FC,
Arjona-Sanchez A, Casado-Adam A, Gómez-Luque I, Garcilazo Arismendi
DJ, Thoelecke H, Rufián Peña S and Briceño Delgado J: Postoperative
time course and utility of inflammatory markers in patients with
ovarian peritoneal carcinomatosis treated with neoadjuvant
chemotherapy, cytoreductive surgery, and HIPEC. Ann Surg Oncol.
22:1332–1340. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mei Z, Shi L, Wang B, Yang J, Xiao Z, Du
P, Wang Q and Yang W: Prognostic role of pretreatment blood
neutrophil-to-lymphocyte ratio in advanced cancer survivors: A
systematic review and meta-analysis of 66 cohort studies. Cancer
Treat Rev. 58:1–13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Templeton AJ, McNamara MG, Seruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106:dju1242014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou WW, Chu YP and An GY: Significant
difference of neutrophil-lymphocyte ratio between colorectal
cancer, adenomatous polyp and healthy people. Eur Rev Med Pharmacol
Sci. 21:5386–5391. 2017.PubMed/NCBI
|
|
39
|
Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB,
Ha TY, Song GW, Jung DH and Lee SG: The impact of tumor size on
long-term survival outcomes after resection of solitary
hepatocellular carcinoma: Single-institution experience with 2558
patients. J Gastrointest Surg. 19:1281–1290. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang X, Wang Z and Wu L: Combined
measurements of tumor number and size helps estimate the outcome of
resection of Barcelona clinic liver cancer stage B hepatocellular
carcinoma. BMC Surg. 16:222016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang TT, Zhao XQ, Liu Z, Mao ZY and Bai
L: Factors affecting the recurrence and survival of hepatocellular
carcinoma after hepatectomy: A retrospective study of 601 Chinese
patients. Clin Transl Oncol. 18:831–840. 2016. View Article : Google Scholar : PubMed/NCBI
|
